alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp

Term ID

CHEBI:146046

Synonyms

(2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-[beta-D-galacto-hexopyranosyl-(1->3)]-beta-D-galacto-hexopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)]-beta-D-galactopyranose
alpha-L-fucopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)]-beta-D-galactopyranose
Fuc(a1-2)[Gal(b1-3)]b-Gal
O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-[beta-D-galactopyranosyl-(1->3)]-beta-D-galactopyranose
WURCS=2.0/2,3,2/[a2112h-1b_1-5][a1221m-1a_1-5]/1-2-1/a2-b1_a3-c1

Definition

An L-Fucp-(1->2)-[D-Galp-(1->3)]-D-Galp in which the disubstituted D-galactosyl residue has beta- configuration at the anomeric centre, while the L-fucosyl group at position 2 and the D-galactosyl group at position 3 have alpha- and beta- configuration, respectively.

References

GlyGen:G00067MO
GlyTouCan:G00067MO
PMID:32568414

Ontology

ChEBI ( EBI )

Relationships

is a type of: L-Fucp-(1->2)-[D-Galp-(1->3)]-D-Galp

L-Fucp-(1->2)-[D-Galp-(1->3)]-D-Galp Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp

Phenotype where environments contain alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp

Human Disease / Model Data